ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Intestinal ulcer perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
6,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
7,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
8,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
8,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
10,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
11,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
12,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
12,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
12,3,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
13,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,Y
14,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
15,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
16,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
17,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
17,2,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
18,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
18,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
19,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
19,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
21,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,4,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
21,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
22,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
23,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
23,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
23,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
25,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
25,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
26,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
26,3,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
26,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
